Raymond J. Henley Iii

Array ( [id] => 6465780 [patent_doc_number] => 20100190750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'GPR119 Receptor Agonists in Methods of Increasing Bone Mass and of Treating Osteoporosis and Other Conditions Characterized by Low Bone Mass, and Combination Therapy Relating Thereto' [patent_app_type] => utility [patent_app_number] => 12/752671 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 97901 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190750.pdf [firstpage_image] =>[orig_patent_app_number] => 12752671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6232116 [patent_doc_number] => 20100184865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Use Of RR/SR-Ractopamine' [patent_app_type] => utility [patent_app_number] => 12/751134 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19144 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184865.pdf [firstpage_image] =>[orig_patent_app_number] => 12751134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733719 [patent_doc_number] => 20120016016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING COMPLICATIONS OF DIABETES AND VASCULAR DISEASES USING FLAVONES' [patent_app_type] => utility [patent_app_number] => 13/255192 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12403 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016016.pdf [firstpage_image] =>[orig_patent_app_number] => 13255192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896794 [patent_doc_number] => 08476315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'N-hydroxy C29-amide derivatives of oleandrane' [patent_app_type] => utility [patent_app_number] => 13/256042 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39945 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527466 [patent_doc_number] => 08044058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Merocyanine derivatives' [patent_app_type] => utility [patent_app_number] => 12/715839 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14037 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044058.pdf [firstpage_image] =>[orig_patent_app_number] => 12715839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351464 [patent_doc_number] => 20100249227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Compositions Containing Zinc Salts For Coating Medical Articles' [patent_app_type] => utility [patent_app_number] => 12/715026 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5139 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249227.pdf [firstpage_image] =>[orig_patent_app_number] => 12715026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663770 [patent_doc_number] => 20110313039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'METHOD FOR INCREASING ENDOGENOUS PLASMALOGEN LEVELS IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 13/254622 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3084 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313039.pdf [firstpage_image] =>[orig_patent_app_number] => 13254622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166723 [patent_doc_number] => 08592400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Drug combinations containing PDE4 inhibitors and NSAIDs' [patent_app_type] => utility [patent_app_number] => 13/201262 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22674 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7740815 [patent_doc_number] => 08106081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Combination of organic compounds useful for treating diabetes' [patent_app_type] => utility [patent_app_number] => 12/705655 [patent_app_country] => US [patent_app_date] => 2010-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5362 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106081.pdf [firstpage_image] =>[orig_patent_app_number] => 12705655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114823 [patent_doc_number] => 08158630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Application of 2,5 -dihydroxymethyl-3,6-dimethyl pyrazine and its derivates in pharmacy' [patent_app_type] => utility [patent_app_number] => 12/703131 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4440 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158630.pdf [firstpage_image] =>[orig_patent_app_number] => 12703131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248854 [patent_doc_number] => 20100137265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'TREATMENT OF CONDITIONS RELATING TO HORMONE DEFICIENCIES BY ADMINISTRATION OF PROGESTINS' [patent_app_type] => utility [patent_app_number] => 12/700078 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5648 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137265.pdf [firstpage_image] =>[orig_patent_app_number] => 12700078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493723 [patent_doc_number] => 07956086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Methods for the formulation and manufacture of artesunic acid for injection' [patent_app_type] => utility [patent_app_number] => 12/658229 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5595 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/956/07956086.pdf [firstpage_image] =>[orig_patent_app_number] => 12658229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778486 [patent_doc_number] => 20120040973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'DERIVATIVES OF [1,3]OXAZIN-2-ONE USEFUL FOR THE TREATMENT OF METABOLIC DISEASES SUCH AS LIPID DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/147637 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27443 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040973.pdf [firstpage_image] =>[orig_patent_app_number] => 13147637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175016 [patent_doc_number] => 20130317002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'FUSED PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 13/201277 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69998 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644437 [patent_doc_number] => 08022042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Composition and methods for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/697169 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 9884 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022042.pdf [firstpage_image] =>[orig_patent_app_number] => 12697169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768061 [patent_doc_number] => 20120035197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Novel Use of Fibrates' [patent_app_type] => utility [patent_app_number] => 13/143152 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6901 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035197.pdf [firstpage_image] =>[orig_patent_app_number] => 13143152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282977 [patent_doc_number] => 08217081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Polymerizable biomedical composition' [patent_app_type] => utility [patent_app_number] => 12/647661 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2331 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12647661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616268 [patent_doc_number] => 20100099705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'ARGATROBAN FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/647841 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3248 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099705.pdf [firstpage_image] =>[orig_patent_app_number] => 12647841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616275 [patent_doc_number] => 20100099706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'ARGATROBAN FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/647854 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3248 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099706.pdf [firstpage_image] =>[orig_patent_app_number] => 12647854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884833 [patent_doc_number] => 20130158017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/140741 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22344 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140741 [rel_patent_id] =>[rel_patent_doc_number] =>)